Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay

Casteele, NV; Yang, LL; Dobler, I; Agboton, C; Osborn, TM; Suri, A; Lindner, D; Smithson, GM

Casteele, NV (通讯作者)，Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92093 USA.

THERAPEUTIC DRUG MONITORING, 2023; 45 (2): 236

Abstract

Background:Vedolizumab (VDZ) is an anti-alpha(4)beta(7) integrin monoclonal antibody approved for inflammatory bowel disease treatment. VDZ serum and ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索